Gene Therapy of Cancer - 11th International Conference: 12-14 December 2002, San Diego, USA
At this excellent meeting, preclinical, phase I and some phase II data were presented concerning significant advances with various viral and non-viral-based vectors. In addition, a few talks discussed genomic-based therapies such as those involving antisense oligomers with novel chemistries and backbone modifications. The presentations covered some of the common issues concerning gene therapy, which include bioavailability, delivery strategies, toxicity and dosing schedules.
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)